<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Insulin therapy is essential for optimal glycemic control during pregnancy in women with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and is frequently required to optimize control in women with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Less commonly, women with <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> mellitus (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e>) require insulin for glycemic control </plain></SENT>
<SENT sid="2" pm="."><plain>However, because of its greater prevalence, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> is the most common reason for insulin use in pregnancy </plain></SENT>
<SENT sid="3" pm="."><plain>The most frequently used insulin regimen in pregnancy is a basal/bolus combination of long- and short-acting insulin preparations </plain></SENT>
<SENT sid="4" pm="."><plain>There is no evidence base to support one treatment regimen over another </plain></SENT>
<SENT sid="5" pm="."><plain>Therapy should be individualized and based on local expertise </plain></SENT>
</text></document>